Jennifer Straumins Sells 37,861 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Jennifer Straumins sold 37,861 shares of the stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $21.42, for a total transaction of $810,982.62. Following the completion of the sale, the director now owns 1,184,589 shares in the company, valued at approximately $25,373,896.38. This trade represents a 3.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Jennifer Straumins also recently made the following trade(s):

• On Tuesday, November 12th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The shares were sold at an average price of $20.59, for a total transaction of $2,059,000.00.

Calumet Specialty Products Partners Price Performance

CLMT stock opened at $20.39 on Monday. The business has a 50-day moving average of $21.31 and a 200-day moving average of $18.13. Calumet Specialty Products Partners, L.P. has a fifty-two week low of $9.97 and a fifty-two week high of $25.29. The stock has a market capitalization of $1.75 billion, a P/E ratio of -7.39 and a beta of 1.91.

Calumet Specialty Products Partners (NASDAQ:CLMT) last posted its quarterly earnings data on Friday, November 8th. The oil and gas company reported ($1.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.59) by ($0.59). The firm had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $888.36 million. The firm’s revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.03 EPS. Equities analysts expect that Calumet Specialty Products Partners, L.P. will post -2.87 EPS for the current year.

Institutional Investors Weigh In On Calumet Specialty Products Partners

Several institutional investors and hedge funds have recently added to or reduced their stakes in CLMT. Raymond James & Associates grew its holdings in shares of Calumet Specialty Products Partners by 13.4% in the 2nd quarter. Raymond James & Associates now owns 572,057 shares of the oil and gas company’s stock valued at $9,182,000 after acquiring an additional 67,689 shares in the last quarter. FAS Wealth Partners Inc. boosted its position in Calumet Specialty Products Partners by 4.5% during the second quarter. FAS Wealth Partners Inc. now owns 54,126 shares of the oil and gas company’s stock valued at $869,000 after purchasing an additional 2,308 shares during the last quarter. Wasserstein Debt Opportunities Management L.P. grew its stake in Calumet Specialty Products Partners by 2.9% in the second quarter. Wasserstein Debt Opportunities Management L.P. now owns 6,891,314 shares of the oil and gas company’s stock valued at $110,606,000 after purchasing an additional 193,063 shares in the last quarter. Wedbush Securities Inc. bought a new stake in shares of Calumet Specialty Products Partners during the 2nd quarter worth approximately $169,000. Finally, DRW Securities LLC acquired a new stake in Calumet Specialty Products Partners in the second quarter valued at $898,000. 34.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CLMT shares. TD Cowen reduced their target price on Calumet Specialty Products Partners from $27.00 to $26.00 and set a “buy” rating on the stock in a report on Monday, November 11th. StockNews.com upgraded Calumet Specialty Products Partners to a “sell” rating in a report on Monday, November 18th. HC Wainwright reissued a “buy” rating and set a $25.00 target price on shares of Calumet Specialty Products Partners in a research note on Monday, November 11th. Finally, Wells Fargo & Company lifted their price target on shares of Calumet Specialty Products Partners from $25.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $23.75.

About Calumet Specialty Products Partners

Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.